REGULATED PRESS RELEASE published on 03/18/2025 at 07:01, 10 months 18 days ago bioMérieux receives FDA 510(k) Clearance for its VITEK® COMPACT PRO, a new ID/AST system to fight against antimicrobial resistance bioMérieux receives FDA 510(k) Clearance for VITEK® COMPACT PRO, a new ID/AST system to combat antimicrobial resistance. The system benefits clinical and industrial laboratories for faster and accurate diagnostics BioMérieux Antimicrobial Resistance FDA Clearance VITEK COMPACT PRO ID/AST System
BRIEF published on 03/14/2025 at 08:40, 10 months 22 days ago 2025 General Meeting: Preparatory Documents Available from bioMérieux Shareholders BioMérieux General Meeting Preparatory Documents Legal Information
BRIEF published on 03/14/2025 at 08:40, 10 months 22 days ago Assemblée Générale 2025 : Documents Préparatoires Disponibles chez bioMérieux Actionnaires BioMérieux Assemblée Générale Documents Préparatoires Informations Légales
REGULATED PRESS RELEASE published on 03/14/2025 at 08:35, 10 months 22 days ago AG 2025 - Avis de mise à disposition des documents préparatoires L'Avis de mise à disposition des documents pour l'Assemblée générale mixte de bioMérieux le 15 mai 2025 est disponible. Consultez le site internet de la Société pour plus d'informations BioMérieux Documents Investisseurs Assemblée Générale Mixte 15 Mai 2025
REGULATED PRESS RELEASE published on 03/07/2025 at 07:01, 10 months 29 days ago bioMérieux – 2024 Financial Results
BRIEF published on 03/04/2025 at 14:41, 11 months ago Statement on the share capital and voting rights of bioMérieux Share Capital Voting Rights BioMérieux Actions February 2025
BRIEF published on 03/04/2025 at 14:41, 11 months ago Déclaration sur le capital social et les droits de vote de bioMérieux Droits De Vote Capital Social BioMérieux Actions Février 2025
REGULATED PRESS RELEASE published on 03/04/2025 at 14:36, 11 months ago Février 2025 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant Communiqué financier de bioMérieux S.A. incluant les informations mensuelles sur les droits de vote et d'actions Société Anonyme Droits De Vote BioMérieux Actions Informations Mensuelles
BRIEF published on 02/13/2025 at 07:06, 11 months 20 days ago BioMérieux Introduces GENE-UP® TYPER for Rapid Food Safety Analysis BioMérieux Food Safety Listeria Monocytogenes GENE-UP® TYPER Pathogen Detection
BRIEF published on 02/13/2025 at 07:06, 11 months 20 days ago BioMérieux dévoile GENE-UP® TYPER pour l'industrie agroalimentaire BioMérieux Listeria Monocytogenes Diagnostic PCR GENE-UP® TYPER Industries Agroalimentaires
Published on 02/05/2026 at 09:05, 3 hours ago BioNxt Secures Innovative Chaperone Technology to Enhance Oral Thin-Film Drug Delivery
Published on 02/05/2026 at 01:35, 10 hours 30 minutes ago Dr. Ruben Shiffman Files Early Warning Report in Respect of Greenland Resources
Published on 02/05/2026 at 00:00, 12 hours 5 minutes ago Onco-Innovations Announces Filing of Preliminary Base Shelf Prospectus
Published on 02/04/2026 at 22:25, 13 hours 40 minutes ago 55 North Mining Announces Flow-Through Financing
Published on 02/05/2026 at 11:47, 18 minutes ago Worthington Steel Announces Start of Acceptance Period for All-Cash Tender Offer of €11.00 per Share to Shareholders of Kloeckner & Co SE
Published on 02/05/2026 at 11:45, 20 minutes ago EQS-WpÜG: Takeover Offer / Target company: Klöckner & Co SE; Bidder: Worthington Steel GmbH
Published on 02/05/2026 at 11:30, 35 minutes ago Linde Reports Full-Year and Fourth-Quarter 2025 Results (Earnings Release Tables Attached)
Published on 02/05/2026 at 11:30, 35 minutes ago Déclaration nombre d'actions et droits de vote - 05.02.2026
Published on 02/05/2026 at 11:30, 35 minutes ago Disclosure of shares outstanding and voting rights - 05.02.2026
Published on 02/04/2026 at 18:04, 18 hours 1 minute ago Total number of voting rights and shares making up the share capital at January 31, 2026
Published on 02/04/2026 at 17:45, 18 hours 20 minutes ago Information concerning the total number of voting rights and shares 2026 01 31
